BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12039827)

  • 1. Unlicensed and off label prescription of drugs to children: population based cohort study.
    'T Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Stricker BH
    BMJ; 2002 Jun; 324(7349):1313-4. PubMed ID: 12039827
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for unlicensed and off-label drug use in children outside the hospital.
    Schirm E; Tobi H; de Jong-van den Berg LT
    Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlicensed and off label drug use by children in the community: cross sectional study.
    Schirm E; Tobi H; de Jong-van den Berg LT
    BMJ; 2002 Jun; 324(7349):1312-3. PubMed ID: 12039826
    [No Abstract]   [Full Text] [Related]  

  • 4. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I; Conroy S
    Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants for drug prescribing to children below the minimum licensed age.
    't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Stricker BH
    Eur J Clin Pharmacol; 2003 Feb; 58(10):701-5. PubMed ID: 12610748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off label prescribing to children in primary care in Germany: retrospective cohort study.
    Bücheler R; Schwab M; Mörike K; Kalchthaler B; Mohr H; Schröder H; Schwoerer P; Gleiter CH
    BMJ; 2002 Jun; 324(7349):1311-2. PubMed ID: 12039825
    [No Abstract]   [Full Text] [Related]  

  • 8. Unlicensed and off-label prescription of respiratory drugs to children.
    't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Strickerf BH
    Eur Respir J; 2004 Feb; 23(2):310-3. PubMed ID: 14979509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of unlicensed and off-label prescription in children.
    Langerová P; Vrtal J; Urbánek K
    Ital J Pediatr; 2014 Feb; 40():12. PubMed ID: 24495454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off label and unlicensed drug use among French office based paediatricians.
    Chalumeau M; Tréluyer JM; Salanave B; Assathiany R; Chéron G; Crocheton N; Rougeron C; Mares M; Bréart G; Pons G
    Arch Dis Child; 2000 Dec; 83(6):502-5. PubMed ID: 11087286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unlicensed and off-label prescription of drugs to children in primary health care: A systematic review.
    Andrade SRA; Santos PANM; Andrade PHS; da Silva WB
    J Evid Based Med; 2020 Nov; 13(4):292-300. PubMed ID: 33047516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label and unlicensed prescribing for children: have we made any progress?
    Waller DG
    Br J Clin Pharmacol; 2007 Jul; 64(1):1-2. PubMed ID: 17577389
    [No Abstract]   [Full Text] [Related]  

  • 13. Unlicensed and off label prescribing of drugs in general practice.
    McIntyre J; Conroy S; Avery A; Corns H; Choonara I
    Arch Dis Child; 2000 Dec; 83(6):498-501. PubMed ID: 11087285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital.
    't Jong GW; Vulto AG; de Hoog M; Schimmel KJ; Tibboel D; van den Anker JN
    Pediatrics; 2001 Nov; 108(5):1089-93. PubMed ID: 11694685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription of drugs contraindicated in children: a national community survey.
    Bensouda-Grimaldi L; Sarraf N; Doisy F; Jonville-Béra AP; Pivette J; Autret-Leca E
    Eur J Clin Pharmacol; 2007 Jan; 63(1):99-101. PubMed ID: 17146659
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
    Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
    Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
    Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
    Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label prescribing to children in the United States outpatient setting.
    Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
    Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off label prescribing in children.
    Banner W
    BMJ; 2002 Jun; 324(7349):1290-1. PubMed ID: 12039809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.